Prostaglandin metabolite levels in patients with schizophrenia

Basit Öğe Kaydı
dc.contributor.authorErşan, E. Erdal
dc.contributor.authorErşan, Serpil
dc.contributor.authorDo?an, Orhan
dc.date.accessioned2024-10-26T17:54:18Z
dc.date.available2024-10-26T17:54:18Z
dc.date.issued2011
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractObjective: Schizophrenia is a neuropsychiatric disease which affects individuals, family members and society. Although many studies have been carried out on the etiopathogenesis of schizophrenia, the condition is not entirely understood. In this study, it has been aimed to measure prostaglandin (PG) metabolite levels in patients with schizophrenia. Methods: The present study measured prostaglandin metabolite levels in 50 schizophrenia patients and 50 healthy volunteers who were matched for age, sex and smoking is similar in terms of, at least two years of patient. Measurements were also taken of 13,14-dihydro-15-keto-PGF2? (PGFM) and 13,14-dihydro-15- keto PGE2 (PGEM). The measurements were performed using High Performance Liquid Chromatography (HPLC) which is a more sensitive device. Statistical analysis of the data was performed using Student's t Test, Chi Square Test, Kruskal-Wallis Test and Mann-Whitney Test. Findings: In the patient group, the PGEM level (0.0807±0.014, t=3.490, p=0.001) and the PGFM level (0.0613±0.0128, t=-7.486, p=0.000) were both significantly lower than in the control group (PGEM 0.0907±0.0146; PGFM 0.0793±0.0113). Discussion: These results suggest that a disorder in phospholipid metabolism may be important in the etiopathogenesis of schizophrenia.
dc.identifier.endpage106
dc.identifier.issn1302-6631
dc.identifier.issue2
dc.identifier.scopus2-s2.0-79955611766
dc.identifier.scopusqualityQ4
dc.identifier.startpage100
dc.identifier.urihttps://hdl.handle.net/20.500.12418/27110
dc.identifier.volume12
dc.indekslendigikaynakScopus
dc.language.isotr
dc.publisherCukurova University, Faculty of Medicine
dc.relation.ispartofAnadolu Psikiyatri Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectFatty acids; Phospholipid metabolism; Prostaglandin; Schizophrenia
dc.titleProstaglandin metabolite levels in patients with schizophrenia
dc.title.alternativeŞizofreni hastalarında plazma prostaglandin düzeyleri
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu